Takeda Pharmaceutical Co Ltd

4502: XTKS (JPN)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|#TlLOCK|^zLOCK|hgdW&PC

Takeda Earnings: Guiding for Another Year of Unchanged Revenue and Core Operating Margin

Takeda reported fourth-quarter revenue of JPY 1.05 trillion, a 2% decline at constant currency but unchanged on a reported basis. Guidance for fiscal 2025's financial metrics, including revenue, core operating margin, and earnings per share, is broadly unchanged from fiscal 2024.

Sponsor Center